{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:13:48Z","timestamp":1788257628760,"version":"build-2803163510"},"reference-count":18,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Med Imag Rad Onc"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Spinal metastases are a common complication of advanced malignancy and can result in significant pain, neurological dysfunction, and reduced quality of life. In patients with oligometastatic disease, stereotactic ablative body radiation therapy (SABR) offers the potential for durable local control. This study reports outcomes following spinal SABR at Waikato Hospital and compares these with published literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single\u2010centre cohort study was conducted of patients with oligometastatic spinal metastases treated with SABR at Waikato Hospital between September 2019 and December 2023. Patient, tumour, and treatment characteristics were collected from electronic records. The primary outcome was freedom from local failure. Overall survival and adverse events were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty\u2010seven patients received 30 courses of spinal SABR. Median age was 66\u2009years (range 37\u201381), 74.1% were male, and prostate cancer was the most common primary malignancy (48.1%). Metachronous oligorecurrent disease was present in 53.3% of patients. Patients received either 24\u2009Gy in 2 fractions (60.0%) or 35\u2009Gy in 5 fractions (40.0%). Median follow\u2010up was 29.7\u2009months. No failures occurred within 12\u2009months. Freedom from local progression was 95.2% (95% CI 86.6\u2013100) at 18\u2009months and 77.6% (95% CI 57.3\u2013100) at 3\u2009years. Overall survival was 88.9% (95% CI 77.8\u2013100) at 1\u2009year and 66.3% (95% CI 49.5\u201388.9) at 3\u2009years. Vertebral compression fractures occurred in\n                      <jats:bold>13.8<\/jats:bold>\n                      % of treated sites.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides important outcome data from a New Zealand tertiary centre and demonstrates the feasibility of spinal SABR, with outcomes which are broadly consistent with those reported internationally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1754-9485.70174","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:21:38Z","timestamp":1788254498000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic Ablative Body Radiation Therapy for Spinal Oligometastases: Experience at a Single New Zealand Institution"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7574-5293","authenticated-orcid":false,"given":"Kathryn","family":"Tucker","sequence":"first","affiliation":[{"name":"Radiation Oncology Department Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komeela","family":"Naidoo","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9091-4371","authenticated-orcid":false,"given":"Nur Azri Bin Mohd","family":"Yasin","sequence":"additional","affiliation":[{"name":"The Brunei Cancer Centre, Pantai Jerudong Specialist Centre  Jerudong Brunei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chin","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles De","family":"Groot","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Huang","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"21","key":"e_1_2_8_2_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14217718","article-title":"Local Control and Vertebral Compression Fractures After Stereotactic Body Radiotherapy for Spinal Metastases","volume":"14","author":"Kim H. U.","year":"2025","journal-title":"Journal of Clinical Medicine"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clon.2022.02.005","article-title":"The Changing Landscape for the Treatment of Painful Spinal Metastases: Is Stereotactic Body Radiation Therapy the New Standard of Care?","volume":"34","author":"Dunne E. M.","year":"2022","journal-title":"Clinical Oncology"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctro.2020.06.011","article-title":"Outcome and Toxicity of Hypofractionated Image\u2010Guided SABR for Spinal Oligometastases","volume":"24","author":"Billiet C.","year":"2020","journal-title":"Clinical and Translational Radiation Oncology"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"109969","DOI":"10.1016\/j.radonc.2023.109969","article-title":"Efficacy and Safety of SBRT for Spine Metastases: A Systematic Review and Meta\u2010Analysis for Preparation of an ESTRO Practice Guideline","volume":"190","author":"Guninski R. S.","year":"2024","journal-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"7","key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.clon.2017.02.004","article-title":"Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases","volume":"29","author":"Chang J. H.","year":"2017","journal-title":"Clinical Oncology"},{"issue":"1","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman S.","year":"1995","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","article-title":"Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations","volume":"33","author":"Guckenberger M.","year":"2023","journal-title":"Seminars in Radiation Oncology"},{"issue":"22","key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A Novel Classification System for Spinal Instability in Neoplastic Disease: An Evidence\u2010Based Approach and Expert Consensus From the Spine Oncology Study Group","volume":"35","author":"Fisher C. G.","year":"2010","journal-title":"Spine"},{"key":"e_1_2_8_10_1","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0","author":"Betheseda M. D.","year":"2017"},{"issue":"1","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and Classification of Oligometastatic Disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer Consensus Recommendation","volume":"21","author":"Guckenberger M.","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery","volume":"83","author":"Cox B. W.","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"e_1_2_8_13_1","unstructured":"NSW Cancer Institute Spinal Bone Metastases Palliative EBRT Stereotactic 2025 Available from https:\/\/www.eviq.org.au\/."},{"issue":"5","key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12032-021-01613-8","article-title":"Stereotactic Body Radiotherapy for Spinal Metastases: A Review","volume":"39","author":"Guo L.","year":"2022","journal-title":"Medical Oncology"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109792","article-title":"Predictors of Pathologic Fracture and Local Recurrence Following Stereotactic Body Radiation Therapy to 505 Non\u2010Spine Bone Metastases","volume":"186","author":"Nguyen E. K.","year":"2023","journal-title":"Radiotherapy and Oncology"},{"issue":"5","key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial","volume":"6","author":"Phillips R.","year":"2020","journal-title":"JAMA Oncology"},{"issue":"5","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or Metastasis\u2010Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial","volume":"36","author":"Ost P.","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","article-title":"Vertebral Compression Fracture After Stereotactic Body Radiotherapy for Spinal Metastases","volume":"14","author":"Sahgal A.","year":"2013","journal-title":"Lancet Oncology"},{"issue":"3","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/neuros\/nyx493","article-title":"Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors","volume":"83","author":"Faruqi S.","year":"2018","journal-title":"Neurosurgery"}],"container-title":["Journal of Medical Imaging and Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1754-9485.70174","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1754-9485.70174","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1754-9485.70174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:21:41Z","timestamp":1788254501000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1754-9485.70174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":18,"alternative-id":["10.1111\/1754-9485.70174"],"URL":"https:\/\/doi.org\/10.1111\/1754-9485.70174","archive":["Portico"],"relation":{},"ISSN":["1754-9477","1754-9485"],"issn-type":[{"value":"1754-9477","type":"print"},{"value":"1754-9485","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"2026-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1754-9485.70174"}}